Rajendiran and colleagues found that miR-940 was highly expressed in normal tissues compared with tumors, and miR-940 inhibited migratory and invasive potential of prostate cancer cells and increased E-cadherin expression by regulating MIEN1. Here, MIEN1 is linked to prostate carcinoma.